Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrinsa Patch Pilot Study
NCT01208038Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Mar 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Testosterone TEPI patch in hypoactive sexual desire disorder (HSDD), sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Arterial Compliance - Augmentation Index at 12 weeks and Endothelial Function at 12 weeks. Started Mar 2011; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT01208038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208038.